Clinical Challenge of Co-Infection of SARS-CoV-2 with Influenza During the Influenza Circulation Season: Suggestions for Prevention
- -
- Observing the guidelines of the World Health Organization (WHO), such as wearing a mask (especially in closed and crowded spaces), washing hands, maintaining a distance of at least 3 feet, and avoiding unnecessary meetings, should be prioritized.
- -
- Vaccines for new strains of influenza and the fourth dose of COVID-19 vaccines should be administered, especially for the high-risk population, such as the elderly, those with underlying conditions, immune-deficient patients, and healthcare staff.
- -
- The production of new influenza vaccines with new technologies which would be effective against new strains of this virus should be prioritized, and surveillance and control of influenza infections should be applied shortly.
- -
- People with symptoms of a common cold should immediately visit a doctor and receive supportive treatment and observe quarantine conditions to prevent the spread of the disease.
- -
- Since the students are attending schools and universities in-person again, the rapid transmission of COVID-19 and influenza has increased. As infection can spread among them easily, people with symptoms of respiratory disease and cold should refrain from attending school or university until full recovery.
- -
- In this situation, the co-infection with influenza and COVID-19 complicates the treatment of patients; if also a co-infection or a secondary infection with bacteria occurs, treatment will be more complicated. Hence, the use of antibiotics in people with symptoms plays a pivotal role in preventing simultaneous bacterial infections, although doctors should prescribe antibiotics according to guidelines to prevent antibiotic resistance.
Author Contributions
Funding
Conflicts of interest
References
- Moghadam, M.T.; Taati, B.; Paydar Ardakani, S.M.; Suzuki, K. Ramadan fasting during the COVID-19 pandemic; observance of health, nutrition and exercise criteria for improving the immune system. Front Nutr. 2021, 7, 570235. [Google Scholar] [CrossRef]
- Taati Moghadam, M.; Babakhani, S.; Rajabi, S.; Baravati, F.B.; Raeisi, M.; Dousari, A.S. Does stress and anxiety contribute to COVID-19? Iran J Psychiatry Behav Sci. 2021, 15, e106041. [Google Scholar] [CrossRef]
- Shokri, A.; Moradi, G.; Moradpour, F.; et al. Influenza incidence overlapped with COVID-19 or under COVID-19 control measures. Immun Inflamm Dis. 2022, 10, e672. [Google Scholar] [CrossRef]
- Shakibnia, P.; Ahmadi, R.H.; Fallah, F.; et al. Iran as the center of challenges in the Middle East for the outbreak of COVID-19 Delta variant. Iran Red Crescent Med J. 2021, 23, e1394. [Google Scholar] [CrossRef]
- Aminzadeh, S.; Moghadam, M.T. What are the reasons for refusing the booster doses of COVID-19 vaccines? Recommendations and Solutions. Iran Red Crescent Med J. 2022, 24, e2175. [Google Scholar] [CrossRef]
- Tenforde, M.W.; Weber, Z.A.; Natarajan, K.; et al. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated Emergency Department or Urgent Care encounters and hospitalizations among immunocompetent adults—VISION Network, nine states, September-November 2022. MMWR Morb Mortal Wkly Rep. 2023, 71, 1637–1646. [Google Scholar] [CrossRef]
- Chung, J.R.; Kim, S.S.; Kondor, R.J.; et al. Interim estimates of 2021-22 seasonal influenza vaccine effectiveness—United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022, 71, 365–370. [Google Scholar] [CrossRef]
- Garg, I.; Gangu, K.; Shuja, H.; et al. COVID-19 and influenza coinfection outcomes among hospitalized patients in the United States: A propensity matched analysis of national inpatient sample. Vaccines 2022, 10, 2159. [Google Scholar] [CrossRef] [PubMed]
- Stańczak-Mrozek, K.I.; Sobczak, A.; Lipiński, L.; et al. The potential benefits of the influenza vaccination on COVID-19 mortality rate-a retrospective analysis of patients in Poland. Vaccines 2021, 10, 5. [Google Scholar] [CrossRef] [PubMed]
- Hashemi, S.A.; Safamanesh, S.; Ghafouri, M.; et al. Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran. J Med Virol. 2020, 92, 2319–2321. [Google Scholar] [CrossRef]
- Mardani, M.; Nasiri, M.J. Influenza and COVID-19 Co-infection. Arch Clin Infect Dis. 2022, 17, e131750. [Google Scholar] [CrossRef]
- Miron, V.D.; Bar, G.; Filimon, C.; Craiu, M. From COVID-19 to influenza—Real-life clinical practice in a pediatric hospital. Diagnostics 2022, 12, 1208. [Google Scholar] [CrossRef] [PubMed]
- Tang, C.Y.; Boftsi, M.; Staudt, L.; et al. SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season. Virology 2022, 576, 105–110. [Google Scholar] [CrossRef]
- Swets, M.C.; Russell, C.D.; Harrison, E.M.; et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet 2022, 399, 1463–1464. [Google Scholar] [CrossRef]
- Centers for Disease Control and Prevention. 2021-2022 Estimated Influenza Burden. 2022. Available online: https://www.cdc.gov/flu/about/burden/2021-2022.htm. 202021-22 (accessed on 26 February 2023).
- Centers for Disease Control and Prevention. Influenza (Flu): 2022-2023. Available online: https://www.cdc.gov/flu/season/faq-fluseason-2022-2023.htm (accessed on 26 February 2023).
- Fanelli, D.; PiazzaF. Analysis and forecast of COVID-19 spreading in China, Italy and France. Chaos Solitons Fractals 2020, 134, 109761. [Google Scholar] [CrossRef]
- Khalil, I.; Barma, P. Sub-continental atmosphere and inherent immune system may have impact on novel corona virus’ 2019 (nCovid-19) prevalence in South East Asia. Mymensingh Med J. 2020, 29, 473–480. [Google Scholar] [PubMed]
- Dadashi, M.; Khaleghnejad, S.; Abedi Elkhichi, P.; et al. COVID-19 and influenza co-infection: A systematic review and meta-analysis. Front Med (Lausanne) 2021, 8, 681469. [Google Scholar] [CrossRef]
- Olsen, S.J.; Winn, A.K.; Budd, A.P.; et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021, 70, 1013–1019. [Google Scholar] [CrossRef]
- Hedberg, P.; Johansson, N.; Ternhag, A.; Abdel-Halim, L.; Hedlund, J.; Nauclér, P. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. BMC Infect Dis. 2022, 22, 108. [Google Scholar] [CrossRef] [PubMed]
- Ozaras, R.; Cirpin, R.; Duran, A.; et al. Influenza and COVID-19 coinfection: Report of six cases and review of the literature. J Med Virol. 2020, 92, 2657–2665. [Google Scholar] [CrossRef]
- Khorramdelazad, H.; Kazemi, M.H.; Najafi, A.; Keykhaee, M.; Emameh, R.Z.; Falak, R. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of co-infection. Microb Pathog. 2021, 152, 104554. [Google Scholar] [CrossRef] [PubMed]
- van Riel, D.; Munster, V.J.; de Wit, E.; et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol. 2007, 171, 1215–1223. [Google Scholar] [CrossRef] [PubMed]
- St John, A.L.; Rathore, A.P. Early insights into immune responses during COVID-19. J Immunol. 2020, 205, 555–564. [Google Scholar] [CrossRef] [PubMed]
- Bai, L.; Zhao, Y.; Dong, J.; et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. 2021, 31, 395–403. [Google Scholar] [CrossRef]
© GERMS 2023.
Share and Cite
Tarzjani, S.D.; Kamalzadeh, S.; Moghadam, M.T.; Ashoobi, M.T. Clinical Challenge of Co-Infection of SARS-CoV-2 with Influenza During the Influenza Circulation Season: Suggestions for Prevention. GERMS 2023, 13, 188-191. https://doi.org/10.18683/germs.2023.1384
Tarzjani SD, Kamalzadeh S, Moghadam MT, Ashoobi MT. Clinical Challenge of Co-Infection of SARS-CoV-2 with Influenza During the Influenza Circulation Season: Suggestions for Prevention. GERMS. 2023; 13(2):188-191. https://doi.org/10.18683/germs.2023.1384
Chicago/Turabian StyleTarzjani, Shabnam Dehghan, Sara Kamalzadeh, Majid Taati Moghadam, and Mohammad Taghi Ashoobi. 2023. "Clinical Challenge of Co-Infection of SARS-CoV-2 with Influenza During the Influenza Circulation Season: Suggestions for Prevention" GERMS 13, no. 2: 188-191. https://doi.org/10.18683/germs.2023.1384
APA StyleTarzjani, S. D., Kamalzadeh, S., Moghadam, M. T., & Ashoobi, M. T. (2023). Clinical Challenge of Co-Infection of SARS-CoV-2 with Influenza During the Influenza Circulation Season: Suggestions for Prevention. GERMS, 13(2), 188-191. https://doi.org/10.18683/germs.2023.1384
 
        
